Applying Recent Advances in the Science of CFTR-based Therapeutics to Improve Outcomes in Patients with Cystic Fibrosis

Applying Recent Advances in the Science of CFTR-based Therapeutics to Improve Outcomes in Patients with Cystic Fibrosis is organized by Academic CME and will be held during Jan 10, 2017 - Jan 09, 2018.

The target audience for this medical event is activity is designed for physicians, nurses, and other healthcare professionals involved in the management of patients with cystic fibrosis. This CME Conference has been approved for a maximum of 2.00 AMA PRA Category 1 Credits.

Conference Objectives are :
• Review and analyze the current clinical trial data for CFTR modulator therapeutics to develop effective individualized treatment plans.
• Discuss the details of real-world outcomes for patients treated with CFTR-based therapeutics.
• Apply the principles of early diagnosis and early pharmaco-therapeutic intervention to the pediatric cystic fibrosis population.
• Understand the science of developing therapeutic options for treating a larger population of cystic fibrosis patients.

Additional details will be posted as soon as they are available.